Alternate Day Buprenorphine Administration, Phase XI - 16 [clinicaltrials:NCT00000234]
Alternate Day Buprenorphine Administration, Phase XI - 16 [clinicaltrials:NCT00000234]
Bio2RDF identifier
NCT00000234
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00000234
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... ce after
open exposure.
brief title [clinicaltrials_vocabulary:brief-title]
Alternate Day Buprenorphine Administration, Phase XI - 16
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-09-20T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-08-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00000234
official title [clinicaltrials_vocabulary:official-title]
Alternate Day Buprenorphine Administration, Phase XI
org study id [clinicaltrials_vocabulary:org-study-id]
NIDA-06969-16
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
R01-06969-16
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-12-01T00:00:00Z
identifier
clinicaltrials:NCT00000234
title
Alternate Day Buprenorphine Administration, Phase XI - 16
@en
type
label
Alternate Day Buprenorphine Administration, Phase XI - 16 [clinicaltrials:NCT00000234]
@en